SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001538210-23-000033
Filing Date
2023-11-17
Accepted
2023-11-17 16:03:42
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nexi-20230930.htm   iXBRL 10-Q 815082
2 EX-31.1 nexi-20230930xexx311.htm EX-31.1 10137
3 EX-31.2 nexi-20230930xexx312.htm EX-31.2 10297
4 EX-32.1 nexi-20230930xexx321.htm EX-32.1 4000
5 EX-32.2 nexi-20230930xexx322.htm EX-32.2 4158
  Complete submission text file 0001538210-23-000033.txt   4808087

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nexi-20230930.xsd EX-101.SCH 38849
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nexi-20230930_cal.xml EX-101.CAL 44733
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nexi-20230930_def.xml EX-101.DEF 175660
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nexi-20230930_lab.xml EX-101.LAB 506459
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nexi-20230930_pre.xml EX-101.PRE 329928
66 EXTRACTED XBRL INSTANCE DOCUMENT nexi-20230930_htm.xml XML 545474
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40045 | Film No.: 231418534
SIC: 2834 Pharmaceutical Preparations